Prolonged overall survival in gastric cancer patients after adoptive immunotherapy

Table 2 Phenotypes of lymphocytes before and after in vitro culture

Phenotype	Before (%)	After (%)	P valuea
CD3+	67.39 ± 7.55	96.71 ± 3.85	< 0.001
CD3+CD4+	33.22 ± 11.57	10.17 ± 8.83	< 0.001
CD3+CD8+	27.85 ± 8.51	79.33 ± 13.58	< 0.001
CD8+CD28+	13.19 ± 6.08	51.01 ± 15.34	< 0.001
CD3-CD16+/CD56+	28.12 ± 12.10	5.56 ± 6.48	< 0.001
CD3+CD16+/CD56+	9.19 ± 6.42	12.73 ± 7.65	0.019
CD45RA+	60.84 ± 8.26	9.74 ± 5.87	< 0.001
CD45RO+	46.53 ± 10.01	94.32 ± 4.57	< 0.001
CD4+CD25+	5.61 ± 4.19	3.17 ± 2.15	0.002
CD4+CD25+CD127-	1.00 ± 0.46	0.94 ± 1.50	0.448
CD29+	62.15 ± 8.77	93.04 ± 3.98	< 0.001
CD4+CD29+	20.11 ± 5.97	12.36 ± 7.55	< 0.001

^aP < 0.05 vs the phenotype before in vitro culture.